Susan Garfield (SPH’11) Named Chief Public Health Officer at EY
The SPH alum and Dean’s Advisory Board member is also a Principal and Commercial Lead in the Health Sciences and Wellness practice.
An experienced strategist, consultant, and thought leader, Garfield fills several critical roles at EY, where she is a Principal and Commercial Lead in the Health Sciences and Wellness practice. In that capacity, she helps life science companies with product launch, commercial strategy and transformations.
This past December, Garfield was named Chief Public Health Officer, Americas at EY, and has been working across government and the private sector on COVID response activation. She is also working to help companies think through their role in driving longer-term health equity through employee wellness and resilience strategies.
With her expertise across the commercial continuum, global market access, and value creation, Garfield’s has held leadership positions in the life sciences field for over 20 years. Before joining EY, Garfield served as executive vice president, healthcare consulting services at GFK, the fourth largest market research company in the world. Prior to GFK, Garfield ran global market access, pricing, advocacy and health economics at QIAGEN (previously Digene), a biotech company, focusing on women’s health, oncology and precision medicine.
Garfield earned her DrPH in Health Policy and Management at SPH in 2011, and has continued to support SPH in several capacities. In addition to her DAB role, she is an idea hub advisory board member. On November 18, Garfield will co-host the SPH45 Anniversary Celebration, a culmination of 45 years of SPH scholarship, research, and practice, along withGary Cohen (SPH ’06); Gloria Respress-Churchwell (PAR SPH’18); Kevin Churchwell (PAR SPH’18); Susan Garfield (SPH ’11); and John Sullivan (MET ’82).
“COVID-19 has amplified the impact of health disparities; the social determinants of health; the intersection of health and climate; urban health; gender and health; and international health disparities, while demonstrating the critical role of epidemiology, health statistics, and—of course—pandemic response,” says Garfield. “Now is the time for the public health community to fight for the values, policies, and funding that will create an enduring difference and more resilient societies globally.”